New cancer institute’s world-leading research and treatment
A new cancer institute in South Australia will deliver world-leading patient care, cutting-edge cancer diagnoses and treatments, and ground-breaking research.
The new South Australian immunoGENomics Cancer Institute (SAiGENCI) has been established with $80 million in funding from the Australian Government, and builds on the collective efforts of the University of ÐÂÀ˲ÊƱ, the State Government of South Australia and the Central ÐÂÀ˲ÊƱ Local Health Network (CALHN).
SAiGENCI will join a network of the world’s leading cancer research institutes to meet the global challenge of developing innovative, new treatments for cancer patients, including in Australia.